Evidence map›Paper›PMID 42180365›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Peripheral TARC (CCL17) Levels Track Widespread Microstructural Vulnerability in Cognitively Unimpaired Older African Americans.

Soodeh Moallemian, Samira Raminfard, Isha Mhatre-Winters, Miray Budak, Bernadette A Fausto, Jason R Richardson, Mark A Gluck

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Soodeh MoallemianSchool of Arts and Sciences, Center for Molecular and Behavioral Neuroscience, Rutgers University - Newark.ORCID 0000-0002-6314-4074
Samira RaminfardDepartment of Psychiatry, University of Pittsburgh.ORCID 0000-0001-9335-7524
Isha Mhatre-WintersDepartment of Physiology and Pharmacology, Isakson Center for Neurological Disease Research, University of Georgia, GA.ORCID 0000-0003-3498-8355
Miray BudakCenter for Molecular and Behavioral Neuroscience, Rutgers University - Newark.ORCID 0000-0003-0552-8464
Bernadette A FaustoCenter for Molecular and Behavioral Neuroscience, Rutgers University - Newark.ORCID 0000-0002-8412-1023
Jason R RichardsonDepartment of Physiology and Pharmacology, Isakson Center for Neurological Disease Research, University of Georgia, GA.ORCID 0000-0003-2448-8963
Mark A GluckCenter for Molecular and Behavioral Neuroscience, Rutgers University - Newark.ORCID 0000-0003-0538-2303

Funding

Risk Factors for Future Cognitive Decline and Alzheimer’s Disease in Older African Americans SUPPLEMENTR01AG053961 · NIA · RUTGERS THE STATE UNIV OF NJ NEWARK · PI MARK A GLUCK · 2018 to 2026
$10.6M
Association of the in Utero Exposome with Life-Course Cognition and Prodromal Alzheimer's Disease in Midlife.RF1NS130713 · NINDS · PUBLIC HEALTH INSTITUTE · PI COHN, BARBARA A, JONES, DEAN PAUL · 2022 to 2022
$2.1M
Association of the in Utero Exposome with Life-Course Cognition and Prodromal Alzheimer's Disease in Midlife.R01NS130713 · NINDS · PUBLIC HEALTH INSTITUTE · PI BARBARA A COHN, Dean Paul Jones · 2025 to 2026
$1.4M
Health Disparities in Alzheimers and Related DiseasesR13AG069380 · NIA · UNIVERSITY OF GEORGIA · PI RICHARDSON, JASON R · 2020 to 2024
$213k
NIA NIH HHS R01 AG053961NIA NIH HHS R13 AG069380NINDS NIH HHS R01 NS130713NINDS NIH HHS RF1 NS130713
6 · The paper itself

Abstract

introductionNeuroinflammation and immune dysregulation are increasingly recognized as early drivers of Alzheimer's disease (AD) and AD-related dementias (AD/ADRD), often emerging decades before the onset of clinical symptoms. Despite this, there remains a critical need for non-invasive biomarkers that can capture these early processes, particularly in African Americans, a population at elevated risk for AD/ADRD yet underrepresented in neuroimaging research. In this study, we investigated the relationship between systemic plasma inflammatory markers and brain microstructural integrity in cognitively unimpaired older African Americans.

methodsForty-one participants (mean age = 68.68 years) underwent MRI scanning and multi-plex plasma-based inflammatory marker quantification. Microstructural changes were quantified using Diffusion Weighted Imaging (DWI) metrics, including mean diffusivity (MD), radial diffusivity (RD), mean kurtosis (MK), and radial kurtosis (RK). Voxel-wise general linear models, and cluster-based models were used to examine associations between plasma-derived inflammatory markers and brain microstructure.

resultsHigher TARC levels were associated with widespread increases in MD and RD across both gray and white matter, implicating reduced microstructural integrity and potential myelin disruption. In contrast, kurtosis-based metrics demonstrated more spatially selective and generally weaker associations, with MK and RK showing limited decreases primarily within white matter tracts. Cluster-level analyses confirmed the robustness of diffusivity findings and highlighted consistent effect sizes across multiple regions. DISCUSSION: These findings suggest that elevated TARC is linked to early microstructural alterations detectable with diffusion MRI, with diffusivity metrics demonstrating greater sensitivity to inflammation-related changes than kurtosis measures in this cohort. This work underscores the importance of incorporating inflammatory biomarkers in neuroimaging studies of aging and highlights diffusion MRI as a promising tool for detecting early neurobiological signatures of AD/ADRD risk in African American populations.

Indexed as

ADRDAfrican AmericansAgingDiffusion MRIEotaxin-3Systemic InflammationTARC

Identifiers

PMID42180365
PMCPMC13193053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.